Clinical Study

Randomized Phase III Study Of Focal Radiation Therapy For Unresectable, Localized Intrahepatic Cholangiocarcinoma

Posted Date: Sep 21, 2017

  • Investigator: Kevin Redmond
  • Co-Investigator: Kevin Redmond
  • Specialties: Hematology/Oncology, Oncology, Cancer, Radiation Oncology
  • Type of Study: Drug

There are two usual approaches for treating this type of cancer, chemotherapy (gemcitabine and cisplatin) or radiation therapy. The purpose of this study is to compare any good and bad side effects of using the combination of gemcitabine and cisplatin wit

Criteria:

To Be Eligible For This Study, Patients Must Have Intrahepatic Cholangiocarcinoma (A Type Of Liver Cancer).

Keywords:

Nrg-Gi001, Icc, Cancer, Unresectable, Intrahepatic Cholangiocarcinoma

For More Information:

Uc Cancer Institute
513-584-7698
kastla@uc.edu

  • Search Clinical Studies

  • Research in the News

    Targeted Treatment Could Prevent Spread of Pancreatic Cancer, Heart Damage

    Researchers at the UC College of Medicine have shown that a new targetedtreatment could benefit patients with certain pancreatic tumors.